DexCom, Inc. (NASDAQ:DXCM) Q2 2019 Results Earnings Conference Call July 31, 2019 4:30 PM ET Company Participants Sean Christensen - Senior Investor Relations Manager Kevin Sayer - Chairman, President and Chief Executive Officer Quentin Blackford - Executive Vice President and Chief Financial Officer Steven Pacelli - Executive Vice President of Strategy and Corporate Development Conference Call Participants Robbie Marcus - JP Morgan J.P. McKim - Piper Jaffray Jeffrey Johnson - Robert W. Baird Margaret Kaczo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 | --- | --- | --- | --- | |---------------------------------------------------------|--------------------|------------- ...

DexCom, Inc. (NASDAQ:DXCM) Q1 2019 Results Conference Call May 1, 2019 4:30 PM ET Company Participants Matt Dolan - Vice President, Corporate Development Kevin Sayer - Chairman, President and Chief Executive Officer Quentin Blackford - Executive Vice President and Chief Financial Officer Steve Pacelli - Executive Vice President of Strategy and Corporate Development Conference Call Participants Jason Bradford - Raymond James Robbie Marcus - JP Morgan Danielle Antalffy - Leerink J. P. McKim - Piper Jaffray Da ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 DEXCOM, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0857544 (State or Other Jurisdiction o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 DEXCOM, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0857544 (State or Other Jurisdiction of Incorporation or Organi ...